Partnership
Roche’s Genentech builds autoimmune Repertoire with deal worth up to $765M
Repertoire, genentech, Autoimmune Diseases, Immune Medicines, Partnership
Illumina and Tempus look beyond cancer in new AI-driven genomics deal
Illumina, Genomics, Partnership, High-Throughput Nucleotide Sequencing, Malignant Neoplasms, Artificial Intelligence, Cardiology discipline, Neurology speciality, Immunology, Genetic Profile, Artificial Intelligence, Market
Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics
OBT, therapeutic autologous dendritic cells, Roche (company), Partnership, Oxford BioTherapeutics, Antibody-Drug Conjugates, biobucks, New
Roche expands obesity pipeline, paying Zealand Pharma $1.65B upfront to codevelop amylin asset
This deal represents a major expansion of Roche’s obesity drug pipeline and a significant partnership in the competitive weight loss medication market.
Daiichi turns to Nosis for AI-designed RNA delivery tech
Nosis, Daiichi, RNA, Sankyo, Partnership, Biosciences, Cells, Chronic disease
Illumina Announces Layoffs as Incyte Forges AI Partnership for Drug Discovery
Illumina, layoffs, Incyte, Genesis Therapeutics, AI partnership, drug discovery, GEMS platform, small molecule therapeutics
Siemens Healthineers Expands U.S. Supply Chain with Strategic ‘Mega Depots’ to Combat Logistics Challenges
Siemens Healthineers, supply chain resilience, mega depots, logistics expansion, healthcare equipment, parts inventory, GXO partnership
Trump 2.0: RFK Confirmation Hearings and Ongoing Clinical Trials Amidst Administrative Changes
Trump 2.0, RFK Confirmation Hearings, Clinical Trials, NIH Grant Reviews, US-India Partnership, Second Term Policies
Gilead and LEO Pharma Collaborate on STAT6 Inflammatory Disease Programmes
Gilead Sciences, LEO Pharma, STAT6, inflammatory diseases, partnership, oral formulations, dermatology
Merck & Co. Enters Oral GLP-1 Market with $2 Billion Hansoh Pharma Deal
Merck & Co., Hansoh Pharma, GLP-1 receptor agonist, oral obesity treatment, pharmaceutical collaboration, biotech partnership